For example, GYY4137 improved myocardial fibrosis by a mechanism involving the inhibition of the TGF-β1/smad2 signaling pathway and a decrease in α-SMA expression in cardiac fibroblasts [150]. The gene discussed is SMAD2; the disease is Myocardial fibrosis.